Variant report
Variant | esv2763145 |
---|---|
Chromosome Location | chr16:79589827-79595961 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs80002373 | chr16:79591005-79591006 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs150826357 | chr16:79591010-79591011 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs539081854 | chr16:79591029-79591030 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs551346888 | chr16:79591048-79591049 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs139226939 | chr16:79591052-79591053 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs73585193 | chr16:79591061-79591062 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs372734852 | chr16:79591067-79591068 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs60175205 | chr16:79591072-79591073 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs369794064 | chr16:79591073-79591074 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs573732153 | chr16:79591076-79591077 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs370700577 | chr16:79591084-79591085 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs556399208 | chr16:79591093-79591094 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs578025014 | chr16:79591128-79591129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs147704104 | chr16:79591137-79591138 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs140797760 | chr16:79591161-79591162 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs183055813 | chr16:79591179-79591180 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs112786706 | chr16:79591188-79591189 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs542913370 | chr16:79591195-79591196 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs145259909 | chr16:79591213-79591214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs371968488 | chr16:79591238-79591239 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs550318734 | chr16:79591248-79591249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs546556428 | chr16:79591253-79591254 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs562444721 | chr16:79591262-79591263 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs186719519 | chr16:79591273-79591274 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs250151 | chr16:79591279-79591280 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs114885698 | chr16:79591291-79591292 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs527612348 | chr16:79591326-79591327 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs528500418 | chr16:79591336-79591337 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs567518312 | chr16:79591338-79591339 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs144986421 | chr16:79591341-79591342 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs556278132 | chr16:79591348-79591349 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs72806527 | chr16:79591351-79591352 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs568471806 | chr16:79591353-79591354 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs530987663 | chr16:79591371-79591372 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs553798251 | chr16:79591394-79591395 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs550658994 | chr16:79591401-79591402 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs572088075 | chr16:79591404-79591405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs542577460 | chr16:79591411-79591412 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs552795455 | chr16:79591434-79591435 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs576627132 | chr16:79591439-79591440 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs570353200 | chr16:79591446-79591447 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs539232894 | chr16:79591447-79591448 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs543661541 | chr16:79591458-79591459 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs250150 | chr16:79591459-79591460 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs149116044 | chr16:79591491-79591492 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs201178435 | chr16:79591499-79591500 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs560224075 | chr16:79591519-79591520 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs527299908 | chr16:79591529-79591530 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs143163509 | chr16:79591549-79591550 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs191614928 | chr16:79591571-79591572 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Schizophrenia | 22958593 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
Prostate cancer | 18632612 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16702952 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Prostate cancer | 19242612 | CNVD |
Cancer | 22429812 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Melanoma | 18172304 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 17001317 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17603634 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 17245344 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Breast cancer | 21806811 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Prostate cancer | 21965145 | CNVD |
Cancer | 21183584 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Lung cancer | 18438408 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Adrenocortical carcinoma | 18281524 | CNVD |
Neurocytoma | 17123091 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Hypoplastic left heart syndrome | 22349727 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:79591000-79591400 | Enhancers | Fetal Intestine Large | intestine |
2 | chr16:79591000-79591800 | Enhancers | Fetal Intestine Small | intestine |
3 | chr16:79593800-79594000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr16:79593800-79594200 | Enhancers | Adipose Nuclei | Adipose |
5 | chr16:79593800-79595400 | Enhancers | Liver | Liver |
6 | chr16:79594000-79595000 | Flanking Active TSS | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
7 | chr16:79594200-79594400 | Flanking Active TSS | Adipose Nuclei | Adipose |
8 | chr16:79594400-79594600 | Enhancers | Adipose Nuclei | Adipose |
9 | chr16:79594600-79594800 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
10 | chr16:79594600-79595000 | Flanking Active TSS | Adipose Nuclei | Adipose |
11 | chr16:79594800-79597000 | Weak transcription | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
12 | chr16:79595000-79599000 | Weak transcription | Adipose Nuclei | Adipose |
13 | chr16:79595400-79595800 | Flanking Active TSS | Liver | Liver |
14 | chr16:79595800-79596200 | Enhancers | Brain Anterior Caudate | brain |
15 | chr16:79595800-79597000 | Enhancers | Brain Substantia Nigra | brain |
16 | chr16:79595800-79597200 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
17 | chr16:79595800-79598200 | Enhancers | Liver | Liver |